Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… VIRAMUNE (nevirapine) Tablets and Suspension, Boehringer Ingleheim NDA 20-636/S20 & 20-933/S10 7/29/03 8/6/03 8/6/03 VIRAMUNE (nevirapine) Tablets and Suspension, Boehringer Ingleheim NDA 20-636/S-016 & 20-933/S-006 12/31/02 1/29/03 4/3/03 Viramune (Nevirapine) Tablets & Solution, Boehringer Ingelheim NDA 20-636/S17 & 20-933/S7 VIRAMUNE (nevirapine) Suspension, Boehringer Ingleheim Pharmaceuticals VIRAMUNE (nevirapine) Tablets, Boehringer Ingleheim Pharmaceuticals | Lamivudine/Zidovudine Tablets co-packaged w/Nevirapine Tablets, Pharmacare Limited, Tentative Approval | Viramune (nevirapine) tablets, Boehringer Ingelheim Pharma, Labeling Revision | Viramune (nevirapine) oral suspension, Boehringer Ingelheim Pharma, Labeling Revision | Nevirapine Tablets, Aurobindo Pharma, Tentative Approval | Nevirapine Tablets, Ranbaxy, Tentative Approval | Nevirapine Tablets, Cipla Ltd., Tentative Approval | Nevirapine Tablets, Strides Acrolab, Tentative Approval | Lamivudine, Stavudine, Nevirapine Tablets, Cipla Ltd., Tentative Approval | Lamivudine/Zidovudine/Nevirapine Tablets, Aurobindo Pharma, Approval | Lamivudine/Zidovudine/Nevirapine Tablets, Cipla Ltd., Tentative Approval | Viramune (nevirapine) Tablets, Boehringer Ingelheim, Labeling Revision | Viramune (nevirapine) Oral Suspension, Boehringer Ingelheim, Labeling Revision | Nevirapine Tablets, Huahai Inc., Tentative Approval | Viramune (nevirapine) Tablets, Boehringer Ingelheim, Labeling Revision | Viramune (nevirapine) Oral Suspension, Boehringer Ingelheim, Labeling Revision | Lamivudine/Stavudine/Nevirapine Dispersible Tablets, Cipla Ltd., Tentative Approval | Nevirapine Tablets, Hetero Drugs, Tentative Approval | Nevirapine Tablets, Emcure Pharma, Tentative Approval | Stavudine/Lamivudine/Nevirapine Tablets, Strides Arcolab, Tentative Approval | Nevirapine Tablets, Matrix Laboratories, Ltd., Tentative Approval | Viramune (nevirapine) Oral Suspension, Boehringer Ingelheim Pharmaceuticals, Inc., Patient Population Altered | Viramune (nevirapine) Tablet, Boehringer Ingelheim Pharmaceuticals, Inc., Patient Population Altered ^ FDA's latest approval appears at the bottom of this list. ^   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News © 2008 Betterchem.com